Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
FDA advisers resoundingly reject BrainStorm's ALS drug
FDA advisers agreed with staffers' concerns about BrainStorm's cell therapy for ALS, voting resoundingly against the treatment's potential efficacy.
Max Bayer
Sep 27, 2023 6:04pm
Roche pays Ionis $60M to license Alzheimer's, Huntington's drugs
Sep 27, 2023 8:56am
Sponsored
Improving the Drug Development Process with Organ-Chips
Sep 25, 2023 8:00am
Gilead ends phase 3 leukemia trial early after data disappoint
Sep 27, 2023 7:48am
Sponsored
Uncover the Rare Disease Patient Journey
Sep 25, 2023 8:00am
Pfizer signs $331M deal with Ginkgo for unspecified targets
Sep 27, 2023 9:50am
Medtech News
Philips suppressed concerns years before CPAP recall: ProPublica
Sep 27, 2023 1:58pm
Deep Genomics puts forward AI model for generating RNA therapies
Sep 27, 2023 11:16am
First patient implanted with Onward BCI to restore arm function
Sep 27, 2023 10:57am
Rockley plows ahead in developing noninvasive glucose sensor
Sep 26, 2023 1:11pm
See More Medtech News